Evidence map›Paper›PMID 19732616›Full record

ReviewClinics in perinatology2009

Fetal effects of psychoactive drugs.

Amy L Salisbury, Kathryn L Ponder, James F Padbury, Barry M Lester

Abstract readReview
In one paragraph

Review in Clinics in perinatology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
15.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Maternal antidepressant effects on the fetal nonstress test.Archives of women's mental health · 2025
    Observational
  3. Review
  4. Article
  5. Prenatal Substance Exposure.Annual review of developmental psychology · 2023
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Cross-national comparison of prenatal methamphetamine exposure on infant and early child physical growth: a natural experiment.Prevention science : the official journal of the Society for Prevention Research · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Amy L SalisburyDepartment of Pediatrics, Brown Center for the Study of Children at Risk, Women and Infants Hospital of Rhode Island, 101 Dudley Street, Providence, RI 02905, USA. amy_salisbury@brown.edu
Kathryn L Ponder
James F Padbury
Barry M Lester
Brown University · USWomen & Infants Hospital of Rhode Island · US

Funding

UTERINE NK CELL HOMING FROM THE PERIPHERAL CIRCULATIONP20RR018728 · NCRR · WOMEN AND INFANTS HOSPITAL-RHODE ISLAND · PI BLISS, JOSEPH MARK · 2003 to 2011
$16.7M
FETAL AND NEONATAL NEUROBEHAVIOR AND PRENATAL ANTIDEPRESSANT EXPOSURE: THE CHILDR01MH078033 · NIMH · WOMEN AND INFANTS HOSPITAL-RHODE ISLAND · PI SALISBURY, AMY L · 2008 to 2017
$6.1M
Maternal antidepressant use and fetal neurobehaviorK23MH065479 · NIMH · WOMEN AND INFANTS HOSPITAL-RHODE ISLAND · PI SALISBURY, AMY L · 2002 to 2006
$647k
NCRR NIH HHS P20 RR018728NCRR NIH HHS P20RR018728NIMH NIH HHS K23 MH065479NIMH NIH HHS MH6547NIMH NIH HHS R01 MH078033
6 · The paper itself

Abstract

Psychoactive drug use by pregnant women has the potential to effect fetal development; the effects are often thought to be drug-specific and gestational age dependent. This article describes the effects of three drugs with similar molecular targets that involve monoaminergic transmitter systems: cocaine, methamphetamine, and selective serotonin re-uptake inhibitors (SSRIs) used to treat maternal depression during pregnancy. We propose a possible common epigenetic mechanism for their potential effects on the developing child. We suggest that exposure to these substances acts as a stressor that affects fetal programming, disrupts fetal placental monoamine transporter expression and alters neuroendocrine and neurotransmitter system development. We also discuss neurobehavioral techniques that may be useful in the early detection of the effects of in utero drug exposure.

Indexed as

CocaineDepressionFemaleFetal DevelopmentFetusHumansMethamphetaminePregnancyPregnancy ComplicationsPrenatal Exposure Delayed EffectsPsychotropic DrugsSelective Serotonin Reuptake InhibitorsSubstance-Related DisordersCocaineMethamphetaminePsychotropic DrugsSelective Serotonin Reuptake Inhibitors

Identifiers

PMID19732616
PMCPMC2767264
OpenAlexW2082516263

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.